Sumitomo Chemical Company, Limited carries a market capitalization of 969.05B, placing it among publicly traded companies globally. Its enterprise value stands at 2.01T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 969.05B |
| Enterprise Value | 2.01T |
Sumitomo Chemical Company, Limited currently has 1.64B shares outstanding.
| Shares Outstanding | 1.64B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 0.53, and the price-to-book ratio stands at 0.96.
| PE Ratio | N/A |
| PS Ratio | 0.53 |
| PB Ratio | 0.96 |
| P/TBV Ratio | 1.13 |
| P/FCF Ratio | 10.42 |
| P/OCF Ratio | 10.41 |
| EV / Sales | 1.60 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 17.70 |
Sumitomo Chemical Company, Limited maintains a current ratio of 1.30, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 137.54, indicating elevated leverage, while an interest coverage ratio of -6.51 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.30 |
| Quick Ratio | 0.25 |
| Debt / Equity | 137.54 |
| Debt / EBITDA | -4.60 |
| Interest Coverage | -6.51 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | N/A |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.36 |
| Income Tax | -595.00M |
| Effective Tax Rate | N/A |
Sumitomo Chemical Company, Limited's stock has gained approximately 71.77986% over the past 52 weeks. The 50-day moving average sits at 540.91, while the 200-day moving average is 490.71.
| Beta (5Y) | N/A |
| 52-Week Price Change | 71.77986% |
| 50-Day Moving Average | 540.91 |
| 200-Day Moving Average | 490.71 |
| Average Volume (20 Days) | N/A |
EBITDA reached -324.66B, while operating income came in at -324.66B.
| Revenue | 1.26T |
| Gross Profit | 243.41B |
| Operating Income | -324.66B |
| Pretax Income | -359.00B |
| Net Income | N/A |
| EBITDA | -324.66B |
| EBIT | -324.66B |
| Earnings Per Share (EPS) | -219.08 |
Sumitomo Chemical Company, Limited holds 323.81B in cash and equivalents against 1.49T in total debt, resulting in a net debt position of 1.22T. Total book value stands at 691.40B, with working capital of 384.85B providing operational flexibility.
| Cash & Cash Equivalents | 323.81B |
| Total Debt | 1.49T |
| Net Debt | 1.22T |
| Equity (Book Value) | 691.40B |
| Book Value Per Share | 422.78 |
| Working Capital | 384.85B |
Sumitomo Chemical Company, Limited produced 64.00B in operating cash flow over the past twelve months.
| Operating Cash Flow | 64.00B |
| Capital Expenditures | N/A |
| Free Cash Flow | 64.00B |
| FCF Per Share | 39.13 |
Sumitomo Chemical Company, Limited operates with a gross margin of 19.32, reflecting its pricing power and cost economics.
| Gross Margin | 19.32 |
| Operating Margin | -25.77 |
| Pretax Margin | -28.49 |
| Profit Margin | N/A |
| EBITDA Margin | -25.77 |
The company's payout ratio of -2.03 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 5.99 |
| Dividend Yield | N/A |
| Payout Ratio | -2.03 |
| Shareholder Yield | 13.65 |
| FCF Yield | 9.60 |
Sumitomo Chemical Company, Limited posts an Altman Z-Score of 0.62, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 0.62 |